PRTK Annual SG&A
$145.60 M
+$26.19 M+21.94%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual selling, general & administrative expenses is $145.60 million, with the most recent change of +$26.19 million (+21.94%) on December 31, 2022. During the last 3 years, it has risen by +$56.46 million (+63.35%).PRTK Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly SG&A
$36.26 M
+$2.77 M+8.29%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly selling, general & administrative expenses is $36.26 million, with the most recent change of +$2.77 million (+8.29%) on June 30, 2023. Over the past year, it has increased by +$5.93 million (+19.55%).PRTK Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK TTM SG&A
-$3.77 B
-$62.73 M-1.69%
30 June 2023
Summary:
As of January 21, 2025, PRTK TTM selling, general & administrative expenses is -$3.77 billion, with the most recent change of -$62.73 million (-1.69%) on June 30, 2023. Over the past year, it has dropped by -$3.90 billion (-3047.76%).PRTK TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.9% | +19.6% | -3047.8% |
| 3 y3 years | +63.4% | +72.9% | -4311.2% |
| 5 y5 years | +293.9% | +180.9% | -4329.1% |
PRTK Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -32.6% | -2494.6% |
Paratek Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $36.26 M(+8.3%) | $157.41 M(+3.9%) |
| Mar 2023 | - | $33.49 M(-37.8%) | $151.48 M(+4.0%) |
| Dec 2022 | $145.60 M(+21.9%) | $53.81 M(+59.0%) | $145.60 M(+7.2%) |
| Sept 2022 | - | $33.85 M(+11.6%) | $135.77 M(+6.2%) |
| June 2022 | - | $30.34 M(+9.9%) | $127.88 M(+2.6%) |
| Mar 2022 | - | $27.60 M(-37.2%) | $124.65 M(+4.4%) |
| Dec 2021 | $119.40 M(+32.9%) | $43.98 M(+69.5%) | $119.40 M(+19.7%) |
| Sept 2021 | - | $25.95 M(-4.2%) | $99.76 M(+5.3%) |
| June 2021 | - | $27.11 M(+21.2%) | $94.71 M(+6.9%) |
| Mar 2021 | - | $22.36 M(-8.1%) | $88.58 M(-1.4%) |
| Dec 2020 | $89.86 M(+0.8%) | $24.34 M(+16.5%) | $89.86 M(+3.5%) |
| Sept 2020 | - | $20.90 M(-0.3%) | $86.78 M(-3.1%) |
| June 2020 | - | $20.98 M(-11.3%) | $89.51 M(+0.1%) |
| Mar 2020 | - | $23.64 M(+11.2%) | $89.45 M(+0.4%) |
| Dec 2019 | $89.14 M(+40.0%) | $21.26 M(-10.0%) | $89.13 M(-4.3%) |
| Sept 2019 | - | $23.64 M(+13.0%) | $93.14 M(+12.1%) |
| June 2019 | - | $20.92 M(-10.3%) | $83.11 M(+10.7%) |
| Mar 2019 | - | $23.32 M(-7.7%) | $75.10 M(+18.0%) |
| Dec 2018 | $63.66 M(+72.2%) | $25.26 M(+85.6%) | $63.66 M(+27.2%) |
| Sept 2018 | - | $13.61 M(+5.4%) | $50.06 M(+12.1%) |
| June 2018 | - | $12.91 M(+8.8%) | $44.67 M(+10.4%) |
| Mar 2018 | - | $11.87 M(+1.8%) | $40.47 M(+9.5%) |
| Dec 2017 | $36.97 M(+40.0%) | $11.67 M(+41.9%) | $36.96 M(+16.2%) |
| Sept 2017 | - | $8.22 M(-5.7%) | $31.80 M(+7.7%) |
| June 2017 | - | $8.72 M(+4.2%) | $29.53 M(+3.9%) |
| Mar 2017 | - | $8.36 M(+28.6%) | $28.42 M(+7.7%) |
| Dec 2016 | $26.40 M(+32.1%) | $6.50 M(+9.3%) | $26.39 M(+3.4%) |
| Sept 2016 | - | $5.95 M(-21.7%) | $25.53 M(+0.6%) |
| June 2016 | - | $7.60 M(+19.9%) | $25.38 M(+15.1%) |
| Mar 2016 | - | $6.34 M(+12.4%) | $22.06 M(+10.3%) |
| Dec 2015 | $19.99 M(+241.8%) | $5.64 M(-2.7%) | $19.99 M(+83.9%) |
| Sept 2015 | - | $5.79 M(+35.4%) | $10.87 M(+23.1%) |
| June 2015 | - | $4.28 M(+0.2%) | $8.82 M(+15.8%) |
| Mar 2015 | - | $4.27 M(-222.7%) | $7.62 M(+30.4%) |
| Dec 2014 | $5.85 M | -$3.48 M(-192.7%) | $5.85 M(-56.4%) |
| Sept 2014 | - | $3.75 M(+21.9%) | $13.41 M(+8.1%) |
| June 2014 | - | $3.08 M(+23.4%) | $12.40 M(-1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $2.50 M(-38.8%) | $12.63 M(-34.4%) |
| Dec 2013 | $19.25 M(+64.7%) | $4.08 M(+48.7%) | $19.25 M(+2.1%) |
| Sept 2013 | - | $2.74 M(-17.2%) | $18.86 M(+1.4%) |
| June 2013 | - | $3.31 M(-63.6%) | $18.60 M(+3.2%) |
| Mar 2013 | - | $9.11 M(+146.7%) | $18.02 M(+54.1%) |
| Dec 2012 | $11.69 M(-4.0%) | $3.69 M(+48.8%) | $11.69 M(-3.7%) |
| Sept 2012 | - | $2.48 M(-9.1%) | $12.14 M(-3.5%) |
| June 2012 | - | $2.73 M(-1.9%) | $12.57 M(+1.2%) |
| Mar 2012 | - | $2.78 M(-32.8%) | $12.43 M(+2.0%) |
| Dec 2011 | $12.19 M(+10.4%) | $4.14 M(+41.8%) | $12.19 M(+13.6%) |
| Sept 2011 | - | $2.92 M(+13.1%) | $10.73 M(-0.6%) |
| June 2011 | - | $2.58 M(+1.5%) | $10.79 M(-1.7%) |
| Mar 2011 | - | $2.54 M(-5.1%) | $10.98 M(-0.5%) |
| Dec 2010 | $11.04 M(-31.2%) | $2.68 M(-10.2%) | $11.04 M(-2.6%) |
| Sept 2010 | - | $2.98 M(+7.8%) | $11.34 M(-7.0%) |
| June 2010 | - | $2.77 M(+6.3%) | $12.19 M(-15.6%) |
| Mar 2010 | - | $2.60 M(-12.6%) | $14.44 M(-10.0%) |
| Dec 2009 | $16.05 M(+102.5%) | $2.98 M(-22.4%) | $16.05 M(+83.8%) |
| Sept 2009 | - | $3.84 M(-23.5%) | $8.73 M(-16.9%) |
| June 2009 | - | $5.02 M(+19.1%) | $10.51 M(+20.8%) |
| Mar 2009 | - | $4.21 M(-197.1%) | $8.70 M(+9.8%) |
| Dec 2008 | $7.92 M(-54.1%) | -$4.34 M(-177.3%) | $7.92 M(-52.4%) |
| Sept 2008 | - | $5.61 M(+74.8%) | $16.65 M(+13.5%) |
| June 2008 | - | $3.21 M(-6.7%) | $14.67 M(-12.9%) |
| Mar 2008 | - | $3.44 M(-21.6%) | $16.84 M(-2.5%) |
| Dec 2007 | $17.28 M(+52.8%) | $4.39 M(+20.7%) | $17.28 M(+3.8%) |
| Sept 2007 | - | $3.63 M(-32.5%) | $16.65 M(+2.8%) |
| June 2007 | - | $5.38 M(+38.9%) | $16.19 M(+20.5%) |
| Mar 2007 | - | $3.88 M(+3.2%) | $13.43 M(+18.8%) |
| Dec 2006 | $11.31 M(+55.9%) | $3.75 M(+18.2%) | $11.31 M(+49.7%) |
| Sept 2006 | - | $3.17 M(+20.9%) | $7.55 M(+72.5%) |
| June 2006 | - | $2.63 M(+50.0%) | $4.38 M(+150.0%) |
| Mar 2006 | - | $1.75 M | $1.75 M |
| Dec 2005 | $7.25 M(+39.1%) | - | - |
| Dec 2004 | $5.21 M(+135.6%) | - | - |
| Dec 2002 | $2.21 M(+267.4%) | - | - |
| Dec 2001 | $602.00 K | - | - |
FAQ
- What is Paratek Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual SG&A year-on-year change?
- What is Paratek Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly SG&A year-on-year change?
- What is Paratek Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals TTM SG&A year-on-year change?
What is Paratek Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of PRTK is $145.60 M
What is the all time high annual SG&A for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual selling, general & administrative expenses is $145.60 M
What is Paratek Pharmaceuticals annual SG&A year-on-year change?
Over the past year, PRTK annual selling, general & administrative expenses has changed by +$26.19 M (+21.94%)
What is Paratek Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of PRTK is $36.26 M
What is the all time high quarterly SG&A for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $53.81 M
What is Paratek Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, PRTK quarterly selling, general & administrative expenses has changed by +$5.93 M (+19.55%)
What is Paratek Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of PRTK is -$3.77 B
What is the all time high TTM SG&A for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high TTM selling, general & administrative expenses is $157.41 M
What is Paratek Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, PRTK TTM selling, general & administrative expenses has changed by -$3.90 B (-3047.76%)